Skip to main content
Log in

Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1

  • Published:
Biochemistry (Moscow) Aims and scope Submit manuscript

Abstract

Prostate cancer is the second leading cause of cancer-related deaths of men. Bmi-1, a member of PcG family of proteins, has been implicated in the pathogenesis of prostate cancer, and disturbed profile of microRNAs (miRNAs) has been found in prostate cancer tissues. How Bmi-1 is regulated by miRNAs is unclear. In this study, we screened 18 miRNAs that potentially repress the expression of Bmi-1 using a dual luciferase system and found that 12 miRNAs could bind with the 3′-untranslated region of Bmi-1 mRNA. Using qRT-PCR, we found that expression of miR-221, -15a, and -30d was significantly reduced in prostate cancer tissues. Subsequent functional study indicated that miR-221 and miR-30d can repress prostate cancer cell proliferation, and this effect can be partially rescued by Bmi-1 overexpression. Our study constructs the relation between downregulated miR-221 and miR-30d and prostate cancer pathogenesis. These results indicate that miR-221 and miR-30d are candidate tumor suppressor miRNAs in prostate cancer and therefore serve as potential clinical classification markers and therapeutic targets for human prostate cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

AGO2:

Argonaute RISC catalytic component 2

Bmi-1:

B-cell specific Moloney leukemia virus insertion region homolog 1 (oncoprotein from PcG (polycomb group))

GAPDH:

glyceraldehyde-3-phosphate dehydrogenase

miRNA:

microRNA

PCa:

prostate cancer

siRNA:

small interfering RNA

3′-UTR:

3′-untranslated region

References

  1. Siddique, H. R., and Saleem, M. (2012) Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences, Stem Cells, 30, 372–378.

    Article  CAS  PubMed  Google Scholar 

  2. Kang, M. K., Kim, R. H., Kim, S. J., Yip, F. K., Shin, K. H., Dimri, G. P., Christensen, R., Han, T., and Park, N. H. (2007) Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival, Brit. J. Cancer, 96, 126–133.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Atala, A. (2013) Re: Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, e3 ligase activity, and DNA damage repair activity in mouse prostate cancer, J. Urol., 189, 771.

    Article  CAS  PubMed  Google Scholar 

  4. Ammirante, M., Kuraishy, A. I., Shalapour, S., Strasner, A., Ramirez-Sanchez, C., Zhang, W., Shabaik, A., and Karin, M. (2013) An IKKalpha-E2F1-BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence, Genes Devel., 27, 1435–1440.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Lukacs, R. U., Memarzadeh, S., Wu, H., and Witte, O. N. (2010) Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation, Cell Stem Cell, 7, 682–693.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Wu, W. K., Lee, C. W., Cho, C. H., Fan, D., Wu, K., Yu, J., and Sung, J. J. (2010) MicroRNA dysregulation in gastric cancer: a new player enters the game, Oncogene, 29, 5761–5771.

    Article  CAS  PubMed  Google Scholar 

  7. Nicoloso, M. S., Spizzo, R., Shimizu, M., Rossi, S., and Calin, G. A. (2009) MicroRNAs — the micro-steering wheel of tumor metastases, Nature Rev. Cancer, 9, 293–302.

    Article  CAS  Google Scholar 

  8. Srivastava, A., Goldberger, H., Dimtchev, A., Marian, C., Soldin, O., Li, X., Collins, S. P., Suy, S., and Kumar, D. (2014) Circulatory miR-628-5p is downregulated in prostate cancer patients, Tumor Biol. J. Int. Soc. Oncodevel. Biol. Med., 35, 4867–4873.

    Article  CAS  Google Scholar 

  9. Qiang, X. F., Zhang, Z. W., Liu, Q., Sun, N., Pan, L. L., Shen, J., Li, T., Yun, C., Li, H., and Shi, L. H. (2014) miR-20a promotes prostate cancer invasion and migration through targeting ABL2, J. Cell. Biochem., 115, 1269–1276.

    Article  CAS  PubMed  Google Scholar 

  10. Ottman, R., Nguyen, C., Lorch, R., and Chakrabarti, R. (2014) MicroRNA expressions associated with progression of prostate cancer cells to anti-androgen therapy resistance, Mol. Cancer, 13, 1.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Bhattacharya, R., Nicoloso, M., Arvizo, R., Wang, E., Cortez, A., Rossi, S., Calin, G. A., and Mukherjee, P. (2009) MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer, Cancer Res., 69, 9090–9095.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Guo, S., Xu, X., Tang, Y., Zhang, C., Li, J., Ouyang, Y., Ju, J., Bie, P., and Wang, H. (2014) miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression, Cancer Lett., 344, 40–46.

    Article  CAS  PubMed  Google Scholar 

  13. Hoffmann, M. J., Engers, R., Florl, A. R., Otte, A. P., Muller, M., and Schulz, W. A. (2007) Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer, Cancer Biol. Ther., 6, 1403–1412.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wei Xue.

Additional information

Published in Russian in Biokhimiya, 2015, Vol. 80, No. 3, pp. 339–347.

Originally published in Biochemistry (Moscow) On-Line Papers in Press, as Manuscript BM14-144, January 25, 2015.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xuan, H., Xue, W., Pan, J. et al. Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1. Biochemistry Moscow 80, 276–283 (2015). https://doi.org/10.1134/S0006297915030037

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0006297915030037

Key words

Navigation